Supriya Lifescience Limited (NSE: SUPRIYA)
595.05
+11.30 (1.94%)
Sep 6, 2024, 3:30 PM IST
Supriya Lifescience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
Net Income | - | 1,191 | 898.57 | 1,518 | 1,236 | 734.03 | Upgrade
|
Depreciation & Amortization | - | 158.11 | 114.43 | 97.52 | 63.69 | 59.84 | Upgrade
|
Other Amortization | - | - | 3.63 | 3.66 | 3.92 | 3.92 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | 1.11 | - | - | - | Upgrade
|
Other Operating Activities | - | -44.76 | 0.52 | -87.74 | 123.52 | -3.18 | Upgrade
|
Change in Accounts Receivable | - | -270.19 | 305.19 | -416.83 | -218.7 | 74.65 | Upgrade
|
Change in Inventory | - | 305.21 | -234.58 | -198.32 | -230.22 | -187.26 | Upgrade
|
Change in Accounts Payable | - | -46.59 | 152.56 | -20.5 | 16.53 | 52.64 | Upgrade
|
Change in Other Net Operating Assets | - | -159.85 | -579.56 | -407.88 | -235.78 | 425.98 | Upgrade
|
Operating Cash Flow | - | 1,133 | 661.87 | 488.01 | 758.89 | 1,161 | Upgrade
|
Operating Cash Flow Growth | - | 71.19% | 35.63% | -35.69% | -34.61% | 138.46% | Upgrade
|
Capital Expenditures | - | -1,457 | -1,084 | -599.04 | -482.41 | -245.25 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 5.43 | 0.82 | 14.4 | - | Upgrade
|
Investment in Securities | - | -385 | -252.43 | - | - | - | Upgrade
|
Other Investing Activities | - | 105.8 | -0.01 | - | - | - | Upgrade
|
Investing Cash Flow | - | -1,736 | -1,331 | -598.22 | -468.01 | -245.25 | Upgrade
|
Short-Term Debt Repaid | - | -166.25 | -46.7 | -486.07 | -92.73 | -18.85 | Upgrade
|
Long-Term Debt Repaid | - | -3.54 | -2.78 | -7.63 | -23.93 | -57.43 | Upgrade
|
Total Debt Repaid | - | -169.79 | -49.48 | -493.7 | -116.66 | -76.28 | Upgrade
|
Net Debt Issued (Repaid) | - | -169.79 | -49.48 | -493.7 | -116.66 | -76.28 | Upgrade
|
Issuance of Common Stock | - | - | - | 2,000 | - | - | Upgrade
|
Common Dividends Paid | - | -48.29 | -48.29 | -43.91 | -39.56 | -176.46 | Upgrade
|
Other Financing Activities | - | -5.51 | 64.09 | 34.13 | 11.06 | -39.56 | Upgrade
|
Financing Cash Flow | - | -223.59 | -33.68 | 1,497 | -145.16 | -292.3 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | 0.01 | - | - | 0.01 | - | Upgrade
|
Net Cash Flow | - | -826.26 | -703.26 | 1,386 | 145.73 | 623.07 | Upgrade
|
Free Cash Flow | - | -323.48 | -422.57 | -111.03 | 276.48 | 915.37 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | -69.80% | 119.37% | Upgrade
|
Free Cash Flow Margin | - | -5.67% | -9.17% | -2.09% | 7.07% | 28.61% | Upgrade
|
Free Cash Flow Per Share | - | -4.02 | -5.25 | -1.38 | 3.78 | 12.51 | Upgrade
|
Cash Interest Paid | - | 5.51 | 30.84 | 36.58 | 38.74 | 61.29 | Upgrade
|
Cash Income Tax Paid | - | 376.45 | 288.56 | 609.62 | 299.94 | 270.05 | Upgrade
|
Levered Free Cash Flow | - | -477.2 | -619.38 | -165.84 | 73.81 | 573.29 | Upgrade
|
Unlevered Free Cash Flow | - | -464.01 | -600.11 | -139.6 | 99.31 | 616.1 | Upgrade
|
Change in Net Working Capital | - | 147.85 | 366.03 | 918.86 | 525.8 | -167.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.